Structure-activity relationships of dopamine agonists.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Annual Review of Pharmacology and Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1146/ANNUREV.PA.23.040183.000535PMID 6347047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of the putative dopamine autoreceptor agonists, 3-PPP and TL-99, with the dopamine-sensitive adenylate cyclase of carp retina.

  1982cited by this paper
• Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.

  1982cited by this paper
• On the preferred rotameric conformation for dopamine agonist action: an illusory quest?

  1982cited by this paper
• The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.

  1982cited by this paper
• Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.

  1982cited by this paper
• Rigid analogues of dopamine: synthesis and interaction of 6-exo- and 6-endo-(3',4'-dihydroxyphenyl)-2-azabicyclo[2.2.2]octanes with dopamine uptake sites and receptors.

  1982cited by this paper
• 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions.

  1981cited by this paper
• Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives.

  1981cited by this paper
• Agents stimulating central dopamine receptors : synthesis and structure-activity relationships

  1981cited by this paper
• Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives.

  1981cited by this paper
• Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.

  1981cited by this paper
• Neurochemical and behavioural profiles of five dopamine analogues

  1981cited by this paper
• 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.

  1981cited by this paper
• Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity.

  1981cited by this paper
• 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.

  1981cited by this paper
• Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.

  1981cited by this paper
• Phenol ionization in dopa determines the site of methylation by catechol-O-methyltransferase.

  1981cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.

  1981cited by this paper
• The vascular dopamine receptor : a review.

  1981cited by this paper
• Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.

  1980cited by this paper
• The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog

  1980cited by this paper
• Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs.

  1980cited by this paper
• Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.

  1980cited by this paper
• Effect of non-catecholic 2-aminotetralin derivatives on dopamine metabolism in the rat striatum

  1980cited by this paper
• Derivatives of 5-hydroxy-6-methyl-2-aminotetralin.

  1980cited by this paper
• The binding of fluorocatecholamines to adrenergic and dopaminergic receptors in rat brain membranes.

  1980cited by this paper
• Topographical model of the renal vascular dopamine receptor.

  1980cited by this paper
• Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.

  1980cited by this paper
• Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists.

  1980cited by this paper
• Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.

  1980cited by this paper
• Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels.

  1980cited by this paper
• [Psychopharmacological profile of a new dopaminergic agonist, RU 24213 (author's transl)].

  1980cited by this paper
• N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.

  1979cited by this paper
• Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist.

  1979cited by this paper
• The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.

  1979cited by this paper
• Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.

  1979cited by this paper
• Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.

  1979cited by this paper
• Pergolide and lisuride for Parkinson's disease.

  1979cited by this paper
• Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.

  1979cited by this paper
• Conformational analogues of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides.

  1979cited by this paper
• N-Alkyl derivatives of (+/-)-alpha-methyldopamine.

  1979cited by this paper
• N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.

  1978cited by this paper
• Conformation of dopamine at the dopamine receptor.

  1978cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper
• Studies on renal dopamine receptors with a new agonist.

  1978cited by this paper
• Dopaminephilic properties of ergot alkaloids.

  1978cited by this paper
• (±)‐(E)‐2‐(3,4‐Dihydroxyphenyl)cyclopropylamine hydrochloride(ASL‐7003): a rigid analogue of dopamine

  1978cited by this paper
• Phenylethylamine and brain function.

  1978cited by this paper
• Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.

  1978cited by this paper
• Direct effect of a nomifensine derivative on dopamine receptors

  1978cited by this paper
• Studies on the dopamine agonist properties of 8‐amino‐2‐methyl‐4‐(3,4‐dihydroxyphenyl)‐1,2,3,4‐tetrahydroisoquinoline, a derivative of nomifensine

  1978cited by this paper
• [3-[2-(Dipropylamino)ethyl]phenol: a new and selective dopaminergic agent (author's transl)].

  1977cited by this paper
• Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting.

  1977cited by this paper
• Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate‐putamen

  1977cited by this paper
• Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.

  1977cited by this paper
• Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.

  1977cited by this paper
• Synthesis and dopaminergic activity of (+/-)-, (+)-, and (-)-2-dipropylamino-5-hydroxy-1,2,3,4-tetrahydronaphthalene.

  1976cited by this paper
• Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.

  1976cited by this paper
• Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.

  1976cited by this paper
• Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.

  1976cited by this paper
• Dopaminergic activity of some apomorphine analogs.

  1976cited by this paper
• Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).

  1976cited by this paper
• Dopaminergic activity of some apomorphine analogs.

  1976cited by this paper
• Photochemistry of diazonium salts. 4. Synthesis of ring-fluorinated tyramines and dopamines.

  1976cited by this paper
• Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain.

  1976cited by this paper
• Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

  1975cited by this paper
• Emetic activity of N-substituted norapomorphines.

  1975cited by this paper
• Synthesis and biological activity of some aporphine derivatives related to apomorphine.

  1975cited by this paper
• Chemistry of dopaminergic agonists.

  1975cited by this paper
• (3,4‐Dihydroxy‐phenylamino)‐2‐imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition

  1975cited by this paper
• Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.

  1975cited by this paper
• Conformations and biological properties of apomorphine and its phenanthro [10, 1-b, c] azepine homologue

  1975cited by this paper
• Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.

  1975cited by this paper
• Norepinephrine uptake sites in cardiac tissue. Lack of affinity of 6-hydroxynorepinephrine and related compounds.

  1975cited by this paper
• Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography

  1974cited by this paper
• Aporphines. 11. Synthesis and dopaminergic acitivity of monohydroxyaporphines. Total synthesis of (plus, minus)-11-hydroxyaporphine, (plus and minus)-11-hydroxynoraporphine, and (plus, minus)-11-hydroxy-N-n-propylnoraporphine.

  1974cited by this paper
• Inhibition of responses to stimulation of the cardioaccelerator nerves of the cat by N,N-dimethyldopamine and apomorphine.

  1974cited by this paper
• Design of agents for stimulation of neostriatal dopaminergic mechanisms

  1974cited by this paper
• Treatment of parkinsonism with bromocriptine.

  1974cited by this paper
• Alpha-methyldopamine derivatives. Synthesis and pharmacology.

  1974cited by this paper
• A molecular orbital study of norepinephrine and 3,4-dihydroxyphenethylamine: a re-evaluation of structure-activity relationships in norepinephrine.

  1973cited by this paper
• Centrally acting emetics. 6. Derivatives of -naphthylamine and 2-indanamine.

  1972cited by this paper
• Quantum mechanical study of the conformational properties of phenethylamines of biochemical and medicinal interest.

  1972cited by this paper
• Centrally acting emetics. 3. Derivatives of beta-naphthylamine.

  1969cited by this paper
• Centrally acting emetics. II. Norapomorphine and derivatives.

  1968cited by this paper
• Metabolism and storage of biogenic amines

  1957cited by this paper

• Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

  2022cites this paper
• Mechanistic insights into dopaminergic and serotonergic neurotransmission – concerted interactions with helices 5 and 6 drive the functional outcome

  2021cites this paper
• Synthesis and Evaluation of Tetrahydroprotoberberines as Dopamine Receptor Ligands

  2017cites this paper
• Functional roles of T3.37 and S5.46 in the activation mechanism of the dopamine D1 receptor

  2017cites this paper
• Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.

  2017cites this paper
• Dopamine D3 agonists in the treatment of Parkinson's disease.

  2015cites this paper
• Dopamine D3 receptor agonists as pharmacological tools.

  2015influential citation
• Molecular determinants of biased agonism at the dopamine D₂ receptor.

  2015cites this paper
• A Small Molecule Scaffold Analysis: Biological Profiles of Novel, Privileged, and Promiscuous Scaffolds

  2013cites this paper
• Progress Towards Development Of Multifunctional, Dopamine D2/d3 Receptor Agonists As Symptomatic And Disease-Modifying Therapeutic Agents For Parkinson's Disease

  2013cites this paper
• Selectivity of dopamine D1 and D2 receptor agonists – A combined computational approach

  2012cites this paper
• Dopamine Receptor Subtype-Selective Drugs: D2-Like Receptors

  2010cites this paper
• Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography.

  2010cites this paper
• Chapter 1 Allelochemical Properties or the Raison D'être of Alkaloids

  2008cites this paper
• The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects.

  2006cites this paper
• Neurotransmitters, Agonists, and Antagonists

  2005cites this paper
• (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

  2005cites this paper
• Dopamine Agonists, Antagonists, and Reuptake Blockers

  2002cites this paper
• Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.

  1999cites this paper
• Antinicotinic Activity of Some 2-Aminotetralin Derivatives

  1999cites this paper
• The medicinal chemistry of 2-aminotetralin-derived benzamides: a novel class of potential atypical antipsychotic agents

  1998cites this paper
• 7TM receptors: 'locks' and 'keys'?

  1996cites this paper
• β-Alkoxy-substituted phenethylamines: a family of compounds potentially active at the dopamine and α-adrenergic receptors

  1995cites this paper
• Synthesis and evaluation of cis-1-methyl-3-n-propyl-2,3,3a,4,5,9b-hexahydro-1H-benz[e]indoles for in vitro dopamine D1 and D2 receptor binding affinity

  1995cites this paper
• On the interaction of the aromatic part of dopaminergic agonists with the receptor.

  1994cites this paper
• Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist.

  1993cites this paper
• cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.

  1993cites this paper
• Ocular actions of an octahydrobenzo[f]quinoline: Ha117.

  1993cites this paper
• Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.

  1991cites this paper
• Structural Requirements for DA2 (peripheral) Dopamine Receptor Agonist Activity

  1991cites this paper
• Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits.

  1990cites this paper
• Biochemical and pharmacological characterization of the putative dopamine autoreceptor agonist benzopyranopyridine, CGS 15873A

  1989cites this paper
• 2H-[1]benzopyrano[3,4-b]pyridines: synthesis and activity at central monoamine receptors.

  1989cites this paper
• SYNTHESIS AND DOPAMINERGIC ACTIVITY OF A NEW OXYGEN ISOSTERE OF THE 2-AMINOTETRALINS - N,N-DIPROPYL-8-HYDROXY-3-CHROMANAMINE

  1988cites this paper
• The Vascular (DA1) Dopamine Receptor

  1988cites this paper
• The Development of Potent and Selective D-2 Agonists of the 2-Aminotetralin Group: Their Clinical Applications and their Use in the Isolation of the D-2 Receptor

  1988cites this paper
• Apomorphine in the evaluation of dopaminergic function in man.

  1988cites this paper
• Dopamine receptor agonists: new angularly annulated tricyclic compounds.

  1988cites this paper
• 7 The Vascular (DA.) Dopamine Receptor

  1988cites this paper
• A Three Dimensional Receptor Model of the Dopamine D2 Receptor from Computer Graphic Analyses of D2 Agonists

  1988cites this paper
• Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.

  1987cites this paper
• Crystallographic, theoretical and molecular modelling studies on the conformations of the salicylamide, raclopride, a selective dopamine‐D2 antagonist *

  1987cites this paper
• Is conformational analysis a key to solve the structure--activity problem of neuroleptics?

  1986cites this paper
• Pharmacological activity of amantadine: effect of N‐alkyl substitution

  1986cites this paper
• Dopaminergic pharmacophore of ergoline and its analogues. A molecular electrostatic potential study.

  1986cites this paper
• Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.

  1986cites this paper
• Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.

  1986cites this paper
• Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.

  1986cites this paper
• Synthesis and dopaminergic activity of trans-6-methyl-7a,8,9,10,11,11a-hexahydro-7H-pyrrolo[3,2,1-gh]- 4,7-phenanthroline and trans-1,2,3,4,4a,5,6,10b-octahydro-4,7-phenanthroline derivatives.

  1986cites this paper
• The Electronic Structure of Dopamine. An ab initio Electrostatic Potential Study of the Catechol Moiety

  1985cites this paper
• Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.

  1985cites this paper
• Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.

  1985cites this paper
• Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.

  1985cites this paper
• (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI): a stimulant of alpha-adrenoceptors and dopamine receptors.

  1984cites this paper
• Dopaminergic activity of a nonhydroxylated aminotetralin derivative (TL-68) on cat hearts.

  1984cites this paper
• Effects of aminotetralins on intraocular pressure and pupillary function in rabbits.

  1984cites this paper
• (3,4‐Dihydroxyphenylimino)‐2‐imidazoline (DPI): a stimulant of α‐adrenoceptors and dopamine receptors

  1984cites this paper
• Transmitters and Receptors in the Basal Ganglia

  1984cites this paper
• Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.

  1984cites this paper
• TL-350, an ergoline derivative with dopamine receptor agonist properties.

  1984cites this paper
• Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.

  1984cites this paper
• Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline.

  1984cites this paper